Vomiting News and Research

RSS
Vomiting is the process the body uses to eject some or all of the contents of the stomach through the mouth.
FDA expands approved use of Janssen Biotech’s Zytiga to treat men with mCRPC

FDA expands approved use of Janssen Biotech’s Zytiga to treat men with mCRPC

Janssen receives FDA approval for ZYTIGA to treat metastatic castration-resistant prostate cancer

Janssen receives FDA approval for ZYTIGA to treat metastatic castration-resistant prostate cancer

Contrast agent ‘not recommended’ in premature neonates

Contrast agent ‘not recommended’ in premature neonates

New survival results from Genentech’s Perjeta Phase III combination study on HER2-positive mBC

New survival results from Genentech’s Perjeta Phase III combination study on HER2-positive mBC

Sanofi announces new data from SAR302503 Phase II trial on myelofibrosis

Sanofi announces new data from SAR302503 Phase II trial on myelofibrosis

Anti-seizure drug benefits women with severe morning sickness

Anti-seizure drug benefits women with severe morning sickness

RedHill Biopharma completes $6.5M private placement

RedHill Biopharma completes $6.5M private placement

Synthetic marijuana linked to 11,406 of 4.9M drug-related ED visits in 2010

Synthetic marijuana linked to 11,406 of 4.9M drug-related ED visits in 2010

New data from AstraZeneca's FASLODEX studies on breast cancer to be presented at SABSC

New data from AstraZeneca's FASLODEX studies on breast cancer to be presented at SABSC

Holiday stress and cold temperatures could lead to heart attacks if left unchecked

Holiday stress and cold temperatures could lead to heart attacks if left unchecked

Pressure Right effectively reduces postdischarge nausea and vomiting

Pressure Right effectively reduces postdischarge nausea and vomiting

Guineafowl may spread Crimean-Congo hemorrhagic fever virus

Guineafowl may spread Crimean-Congo hemorrhagic fever virus

Eisai announces FDA acceptance of AcipHex NDA for priority review

Eisai announces FDA acceptance of AcipHex NDA for priority review

Study: Controversial treatment for autism spectrum disorder may be harmful

Study: Controversial treatment for autism spectrum disorder may be harmful

Novartis to highlight key data from extensive oncology portfolio at SABCS and ASH meeting

Novartis to highlight key data from extensive oncology portfolio at SABCS and ASH meeting

CSL, PharmaJet partner for needle-free delivery of Afluria influenza vaccine

CSL, PharmaJet partner for needle-free delivery of Afluria influenza vaccine

UCB to sponsor key sets of VIMPAT C-V data at 66th American Epilepsy Society annual meeting

UCB to sponsor key sets of VIMPAT C-V data at 66th American Epilepsy Society annual meeting

Digoxin increases risk of death in patients with atrial fibrillation

Digoxin increases risk of death in patients with atrial fibrillation

FDA grants Seattle Genetics orphan drug designation for ADCETRIS to treat mycosis fungoides

FDA grants Seattle Genetics orphan drug designation for ADCETRIS to treat mycosis fungoides

Positive results from Genentech Avastin plus temozolomide Phase III study on glioblastoma

Positive results from Genentech Avastin plus temozolomide Phase III study on glioblastoma

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.